Latest news and press releases about ClearPoint Neuro, Inc. (CLPT): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure.
Price
| Price | $13.40 |
| Market Cap | $402M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 37.79 |
| EV / EBITDA | -16.27 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -188.09% |
| Return on Invested Capital | -40.49% |
| Return on Assets | -39.85% |
| Gross Margin | 62.61% |
| Operating Margin | -73.42% |
| Net Margin | -81.76% |
Related companies: AKBA · AVNS · CMPS · CTKB · LAB · OFIX · SIBN
Explore sector: Healthcare · Medical - Devices
More sections of CLPT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks